IO Biotech IOBT Stock
IO Biotech Price Chart
IO Biotech IOBT Financial and Trading Overview
| IO Biotech stock price | 0.98 USD |
| Previous Close | 1.61 USD |
| Open | 1.6 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1200 |
| Day's Range | 1.56 - 2.14 USD |
| 52 Week Range | 1.56 - 5.77 USD |
| Volume | 2.42M USD |
| Avg. Volume | 133.02K USD |
| Market Cap | 59.07M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.45 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.25 USD |
IOBT Valuation Measures
| Enterprise Value | -79303424 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.96244127 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.47552773 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 1.099 |
Trading Information
IO Biotech Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -46.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.77 USD |
| 52 Week Low | 1.56 USD |
| 50-Day Moving Average | 1.97 USD |
| 200-Day Moving Average | 2.46 USD |
IOBT Share Statistics
| Avg. Volume (3 month) | 133.02K USD |
| Avg. Daily Volume (10-Days) | 699.91K USD |
| Shares Outstanding | 28.82M |
| Float | 8.36M |
| Short Ratio | 14.99 |
| % Held by Insiders | 11.13% |
| % Held by Institutions | 78.95% |
| Shares Short | 425.74K |
| Short % of Float | 2.60% |
| Short % of Shares Outstanding | 1.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.67% |
| Return on Equity (ttm) | -44.85% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -72187504 USD |
| Net Income Avi to Common (ttm) | -71298000 USD |
| Diluted EPS (ttm) | -1.82 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 128.53M USD |
| Total Cash Per Share (mrq) | 4.46 USD |
| Total Debt (mrq) | 2.83M USD |
| Total Debt/Equity (mrq) | 2.28 USD |
| Current Ratio (mrq) | 12.771 |
| Book Value Per Share (mrq) | 4.311 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -53575000 USD |
| Levered Free Cash Flow (ttm) | -26925124 USD |
Profile of IO Biotech
| Country | United States |
| State | N/A |
| City | Copenhagen |
| Address | Ole Maaløes Vej 3 |
| ZIP | 2200 |
| Phone | 45 70 70 29 80 |
| Website | https://www.iobiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 57 |
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
Q&A For IO Biotech Stock
What is a current IOBT stock price?
IO Biotech IOBT stock price today per share is 0.98 USD.
How to purchase IO Biotech stock?
You can buy IOBT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IO Biotech?
The stock symbol or ticker of IO Biotech is IOBT.
Which industry does the IO Biotech company belong to?
The IO Biotech industry is Biotechnology.
How many shares does IO Biotech have in circulation?
The max supply of IO Biotech shares is 65.88M.
What is IO Biotech Price to Earnings Ratio (PE Ratio)?
IO Biotech PE Ratio is now.
What was IO Biotech earnings per share over the trailing 12 months (TTM)?
IO Biotech EPS is -1.45 USD over the trailing 12 months.
Which sector does the IO Biotech company belong to?
The IO Biotech sector is Healthcare.
IO Biotech IOBT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
- {{ link.label }} {{link}}